Xencor, Inc.
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES

Last updated:

Abstract:

The present invention is directed to bispecific, heterodimeric checkpoint antibodies.

Status:
Application
Type:

Utility

Filling date:

16 Mar 2022

Issue date:

30 Jun 2022